Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

CAH · Cardinal Health, Inc.

$236.02 -1.66% Sep 10 close
Detected setup Trend Only · Setup Score 71/100

Stand aside — setup invalidated

Setup score 71, but distribution days reach 5 or more — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about CAH

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$CAH

Cardinal Health, Inc.

Cardinal Health, Inc. is a large-cap Medical Distributors company in the Distribution Services sector with a market cap of $55B.

Distribution Services Medical Distributors stock Stage 2 · Advancing Base 2
$236.02 latest close
Verdict · setup score 71/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 71, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

CAH-1.66%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. -1.06 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-1.66% From the open-1.90% Range position5% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $236.02 -1.7% Sep 10 close
52W High $258.30 8.6% below high
Wks Since High 0w 4w today
Base Depth 5.1% 11.9% today
RS Rank 43 percentile of scan
SMA 50 $234.32
Avg Vol 1,954,163
Rel Vol (Sep 10) 0.62×
More stats
52W Low $145.87
Tight Wks 0
Base B2
SMA 200 $216.23
RS Line vs High -7.1%
RS Line Slope +4.8% ▲
Group Rank #38/58
ADR% 2.0%
ATR(14) $4.70 (2.0%)
Vol Pace (live) N/A
U/D Vol 1.06
A/D Days 20A / 13D
A/D Rating A+
VDU Bars 0/10 d
Position in 52-week range 80thpercentile of the 52-week range
$145.87low
$258.30high

CAH Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for CAH.

Create Free Account

Technical Analysis Report Card

$CAH · $236.02 · as of 2026-09-10 · multi-factor read
68
/ 100
Technicals 68/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$234.32 ↑
100-day$220.34 ↑
200-day$216.23 ↑
Bullish (50 > 200)

RSI (14)

Reading48.9 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.041

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width45% · 9.1%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol1.06 · Neutral
Rel volume0.62×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $243.21swing level
R · $258.3052-week high
Price · $236.02now
S · $227.68swing level
S · $220.37swing level
S · $213.58swing level

Fibonacci · Uptrend swing

23.6%$239.93
38.2%$228.56
50.0%$219.38
61.8%$210.19
78.6%$197.11

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for CAH — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about CAH
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B

Trend-template read: 8/10 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $236.02, MA150 $219.44, MA200 $216.23
1.2 150-day MA > 200-day MAMA150 $219.44 vs MA200 $216.23
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 52
2. Revenue growth ≥ 20% YoY+14.2% YoY
8/10 checks
Avoid
O'Neil D

CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).

Passing evidence
C: Quarterly EPS acceleration ≥ 25%+70.1% QoQ
A: Annual earnings & revenue qualityRev +14.2% | ROE 37.2%
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 52
S: Volume ≥ 40% above average on breakoutVolume ratio 0.62x
4/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $236.02 vs MA200 $216.23
Failing evidence
Volume expansion above averageVolume ratio 0.62x
Relative strength ≥ 60RS 52
4/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$236.02
Distance from 52-week high8.6% below high
Failing evidence
Relative strengthRS 52
Volume vs average0.62x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$236.02
Distance from 52-week high8.6% below high
Failing evidence
Relative strengthRS 52
Volume vs average0.62x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$236.02
Distance from 52-week high8.6% below high
Failing evidence
Relative strengthRS 52
Volume vs average0.62x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Bearish Engulfing — Today's down candle engulfs yesterday's up candle — a bearish reversal warning, most significant after an extended advance.

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
136RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +7 A+
A: 20 D: 13 Net: +765 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 4/7 met
B 4/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ +70%
Revenue growth ≥20% YoY +14%
Gross margin ≥30% 4%
ROE ≥17% 37%
RS rating ≥80 (leadership) 52
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -8.6%

Method Playbook

Trade it like Weinstein EXACT LEVELS · PRO
Weinstein C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Forming Patterns (predictive — not confirmed)

Head & Shoulders bearish near confirmation
90% built

Possible head & shoulders top — not confirmed. Watch for a daily close below ~231.49 (neckline) to confirm, with measured-move risk toward ~204.69. A push back above 240.88 weakens the pattern; reclaiming 258.30 invalidates it.

Confirms below 231.49
Invalidates at 258.30
Left Shoulder 243.21
Head 258.30
Right Shoulder 240.88
Neckline 231.49
Target 204.69

LS 243.21 / head 258.30 / RS 240.88, neckline ~231.49, vol_fading=yes

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

71 setup score
RS Score 52
Trend template 7/8
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • A relative-strength leader — not met RS rank 43 — laggard
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.6× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $236.02 vs SMA150 $219.44 / SMA200 $216.23
SMA 150 above SMA 200 SMA150 $219.44 vs SMA200 $216.23
SMA 200 trending up Slope +4.34 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $234.32
Price above SMA 50 $236.02 vs SMA50 $234.32
30%+ above 52-week low +61.8% from $145.87
Within 25% of 52-week high -8.6% from $258.30
RS score above 70 RS 52

Fundamentals

52W Range
80%
Mkt Cap SEC
54.9B
EPS QoQ
+70%
Rev YoY
+14%
ROE
37%
Gross Margin
4%
D/E
3.48
EPS TTM
$7.23
P/E TTM
32.6x
Float
233M

Company

Company profile
Cardinal Health, Inc.
CAH · NYSE · Distribution Services · Medical Distributors

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
81
W. Support
$180.45
W. Resist
$258.30
W. Patterns
Base Breakout
Weekly Structure

Scan History

Sep 09: 79 (Wyckoff SOS)Sep 10: 79 (Trend Only)Sep 10: 80 (Trend Only)Sep 10: 80 (Trend Only)Sep 11: 70 (Trend Only)Sep 11: 71 (Trend Only)71
Sep 11
Trend Only ✓ Gate
71
Sep 11
Trend Only ✓ Gate
70
Sep 10
Trend Only ✓ Gate
80 0.0%
Sep 10
Trend Only ✓ Gate
80 0.0%
Sep 10
Trend Only ✓ Gate
79 0.0%
Sep 09
Wyckoff SOS ✓ Gate
79 -1.7%

Get the full picture on CAH

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial